{
    "code": "06020831",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06020831",
    "time": "2019-10-25 03:05:40",
    "許可證字號": "衛署醫器輸字第020831號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "114\/02\/24",
    "發證日期": "99\/02\/24",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00602083102",
    "中文品名": "威樂準 病毒血清品管液II",
    "英文品名": "VIROTROL II",
    "效能": "威樂準 病毒血清品管液II是一非分析性的陽性品管物。係由經過處理的人類血漿或血清備製而成，要和偵測B型肝炎表面抗原抗體(anti-HBs)的體外分析程序以及A型肝炎抗體(anti-HAV)定性分析程序一起使用。",
    "醫器規格": "新增規格：00104A (1瓶x5毫升)及00104B (1瓶x5毫升)。",
    "劑型": "",
    "包裝": "",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "主成分略述": "",
    "主製造廠": {
        "申請商名稱": "0939801100  美商伯瑞股份有限公司台灣分公司",
        "申請商地址": "台北市松山區南京東路4段126號14樓",
        "主製造廠": "",
        "製造廠名稱": "MUS1707000  BIO-RAD LABORATORIES",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "醫器輸字第020831-103-05-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06020831&Seq=002&Type=9"
        },
        {
            "title": "06020831001___20121114.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06020831&Seq=001&Type=9"
        },
        {
            "title": "06020831001___20121114.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06020831&Seq=001&Type=8"
        }
    ]
}